http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010516812-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 |
| filingDate | 2008-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010516812-A |
| titleOfInvention | Mitotic kinase modulators |
| abstract | Given that multiple mitotic kinases play a role in tumor cell division and proliferation, having a compound that can inhibit one or more of these multiple mitotic kinases to treat cancer desirable. The present invention relates to compounds of formula (I), prodrugs, polymorphs, tautomers, enantiomers, stereoisomers, solvates, N-oxides or pharmaceutically acceptable salts thereof. It exerts the effect of inhibiting one or more protein kinases involved in cell mitosis. [Selection figure] None |
| priorityDate | 2007-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1055.